Research articlePublished 22 Feb 2019
Behavioural Intention to Adopt Pharmacogenomics and its Predicting Factors in Malaysia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Advances in pharmacogenomics technology research have, to a great extent, uncovered the differences in the genetic basis of interindividual responses to medication. Pharmacogenomics (PGx) is an evolving area in precision medicine with the goal of identifying an individual’s response to drugs, detecting those at risk of developing adverse events, and guiding healthcare providers in terms of selecting the correct drug dose. This technology is useful with regard to improving both the efficacy and the safety of drug prescribing. The successful development and implementation of this technology is highly dependent on public acceptance, which is reflected in their intention to adopt this technology. Therefore, this paper aims to assess the intention of the Malaysian stakeholders to adopt PGx and its associated predictors. Results of the study showed that the Malaysian stakeholders were moderately engaged with medical genetics, have high trust in the key players and were highly religious. Additionally they perceived PGx as highly beneficial and rated the risks and moral aspects as moderate which translated into high intention to adopt PGx.
Subjects
Business & ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAcademy of Strategic Management Journal
- SubjectBusiness & Management
- BylineArticles whose byline prints “Muhammad Adzran Che Mustapa”
- BylineArticles whose byline prints “Latifah Amin”
- BylineArticles whose byline prints “Muhammad Rizal Razman”
